We, survivors, often express our gratitude for life, love, support and research, but what about the patients who do not ...

Tevimbra approved for HER2-negative gastric or gastroesophageal junction adenocarcinoma with PD-L1 expression, in combination ...

An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with ...

A patient advocate discusses the difficulties of finding and participating in clinical trials for MPNs, and the impact on ...

When we got back from the beach, fall was in the air, and we both were back in the reality of doctor appointments, CT scans, ...

CURE® highlights some of the top stories from SABCS, including those focused on older and younger patients with breast cancer ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory ...

One of this year’s MPN Heroes® talked about the importance of a supportive care team, especially as every patient with MPN ...

In February 2024, the FDA approved Onivyde (irinotecan liposome) with oxaliplatin, fluorouracil and leucovorin for the ...

This Christmas, my wish for all of you is that you read this and feel seen, that someone out there knows how very hard this ...

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple ...